Lipoprotein ‘A’ and fibrinogen are not tested routinely in patients in India even in corporate and private hospitals. Even in reangiography group, it is not done. My experience is that Lipoprotein’ A’ can be one of the reasons for reocclusion or new lesion in CAD. So, by estimating it and treating it with available nicotinic acid, a positive outcome can be expected.
I have come across a lady of 42 years who developed AMI in her forties and treated with single stent. Later within two years she developed two more occlusive vessels and done PTCA once again. While this patient was worked up, she had a fourfold increase in Lipoprotein A and now after treating her increased Lipoprotein A ,she is better and the stent patency was confirmed by CT Coronary Angiography recently and no new lesions noted in other arteries.This case history tells about the vivid story of how we can prevent CAHD in…
